NEW YORK (GenomeWeb) – The National Institutes of Health has awarded an approximately $2.8 million Phase IIB Small Business Innovation Research (SBIR) grant to microRNA diagnostics firm DiamiR.

The three-year grant from the National Institute on Aging will help the company develop its first test, CogniMir, CEO Kira Sheinerman said in a statement. The test is targeted at early-stage Alzheimer's disease patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.